Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sandra McAllister, Ph.D.

Co-Author

This page shows the publications co-authored by Sandra McAllister and Jessalyn Ubellacker.
Connection Strength

2.579
  1. Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer. Cancer Res. 2018 09 15; 78(18):5300-5314.
    View in: PubMed
    Score: 0.772
  2. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells. Breast Cancer Res. 2017 03 06; 19(1):23.
    View in: PubMed
    Score: 0.700
  3. The unresolved role of systemic factors in bone metastasis. J Bone Oncol. 2016 Sep; 5(3):96-99.
    View in: PubMed
    Score: 0.662
  4. Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer. Cancer Discov. 2019 09; 9(9):1208-1227.
    View in: PubMed
    Score: 0.205
  5. IL-1ß inflammatory response driven by primary breast cancer prevents metastasis-initiating cell colonization. Nat Cell Biol. 2018 09; 20(9):1084-1097.
    View in: PubMed
    Score: 0.194
  6. CDK4/6 inhibition triggers anti-tumour immunity. Nature. 2017 08 24; 548(7668):471-475.
    View in: PubMed
    Score: 0.045
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.